"At all of our Arthritis Centers, our physicians are specialists in the diagnosis and treatment of rheumatic diseases, connective tissue diseases, arthritis, and osteoporosis. Also, all of our physicians have completed fellowships and residencies in Rheumatology and Internal Medicine. Also, all of our physicians are board certified in Rheumatology. Call to make an appointment today!"

During the past decade, Sarasota Arthritis Research Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 17 clinical trials were completed, i.e. on average, 212.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sarasota Arthritis Research Center" #1 sponsor was "Bristol-Myers Squibb" with 7 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "CSL Behring" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sarasota Arthritis Research Center" #1 collaborator was "Oregon Health and Science University" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Sarasota Arthritis Research Center" are "Rheumatoid Arthritis" (20 trials), "Psoriatic Arthritis" (4 trials), "Axial Spondyloarthritis" (2 trials), "Spondyloarthritis" (2 trials) and "Ankylosing Spondylitis" (1 trials). Many other conditions were trialed in "Sarasota Arthritis Research Center" in a lesser frequency.

Most popular intervention types in "Sarasota Arthritis Research Center" are "Drug" (30 trials), "Biological" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Abatacept" (5 trials), "Methotrexate" (5 trials), "Adalimumab" (4 trials) and "Ixekizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Sarasota Arthritis Research Center" are 34 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sarasota Arthritis Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Sarasota Arthritis Research Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Sarasota Arthritis Research Center, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".